Project Grant HT94252310818
Award Date
9/15/23
Completion Date
9/14/25
Dollars Obligated
$2.3M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Richardson, TX 75080, USA
Similar Awards
This $2,763,615 federal Project Grant award from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) supports a randomized controlled trial of brief prolonged exposure therapy for injured individuals admitted to a Level I trauma center. The goal is to evaluate the effectiveness of this approach in preventing post-traumatic stress disorder (PTSD) in this patient population. The 4-year study is being conducted by the Baylor Research Institute, a...
This $3,141,404 federal Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) aims to evaluate the efficacy of combined cognitive processing therapy and stellate ganglion blocks for treating post-traumatic stress disorder (PTSD). The award, dated September 1, 2024, supports a randomized controlled trial to be conducted by the Rush University Medical Center in Chicago, Illinois over a 4-year performance period ending August...
The National Institute of Mental Health awarded Evren Technologies, Inc. a $769,743 project grant under the Mental Health Research Grants program (CFDA 93.242) to develop a personalized transcutaneous vagal nerve stimulation device for post-traumatic stress disorder research and treatment. Evren will create the Phoenix Laboratory, the first non-invasive vagal nerve stimulator designed to meet the complex needs of both researchers and patients. In Phase I, Evren will develop the stimulator and...
The University of Texas Health Science Center of San Antonio will receive $3 million in cooperative agreement funding from the Department of the Army Medical Command to conduct a randomized clinical trial combining stellate ganglion block with prolonged exposure therapy for post-traumatic stress disorder (PTSD). The four-year award under the Military Medical Research and Development program (CFDA 12.420) aims to investigate medical solutions for traumatic battlefield injuries and transform...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $2,384,097.00 to The University of Texas Health Science Center at San Antonio (UTHSCSA) to conduct a hybrid experimental clinical trial examining tailored intervention sequencing to maximize the effectiveness of PTSD treatment. The award period runs from August 15, 2024 to August 14, 2028.
As part of this project, UTHSCSA is sub-awarding funding to...
The U.S. Defense Health Agency awarded a $2,398,281 Project Grant on September 1, 2024 under the Military Medical Research and Development program (CFDA 12.420) to the Palo Alto Veterans Institute for Research (PAVIR). The grant, titled "Increasing Access to Evidenced-Based PTSD Treatment in the Military: Behavioral Health Technician-Delivered Written Exposure Therapy", aims to determine the effectiveness, acceptability, and fidelity of a Behavioral Health Technician (BHT)-delivered...
This $1,312,801 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports the development of an advanced wireless augmented reality-enhanced exposure therapy for post-traumatic stress disorder (PTSD). The prime awardee, Wayne State University, will collaborate with the University of Texas Health Science Center at Houston and the Lowcountry Center for Veterans Research to execute the project.
Key activities...
This $2,997,922 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) will fund research at Florida State University (FSU) to develop rapid, non-invasive brain stimulation treatments for post-traumatic stress disorder (PTSD). The award, which runs from September 30, 2024 to September 29, 2028, will enable FSU's Sponsored Research Administration division to conduct cutting-edge scientific studies to advance...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $737,899.00 to The University of Texas Health Science Center at San Antonio (UTHSCSA) to conduct research on a nontrauma intervention to treat post-traumatic stress disorder (PTSD) for veterans and service members suffering from a traumatic brain injury (TBI). The award will support this investigative work over a 3-year period from September 1, 2024 to...
The U.S. Defense Health Agency awarded a $2,534,532 Project Grant to Rush University Medical Center to evaluate evidence-based options for initial PTSD treatment non-responders. This grant is funded through the Military Medical Research and Development program (CFDA 12.420), which supports a comprehensive range of biomedical research initiatives aimed at improving health outcomes for military service members, veterans, and the broader public. The award has a performance period of September 1,...